Australia, June 26 -- Axsome Therapeutics Inc., owns the trademark (2639772) for 'RIVILY' till March 27, 2036.
Status: registered:
Registered/protected
Classes: 5 [Medicated and pharmaceutical preparations for use in connection with humans, namely, antibiotics, antifungals preparations, antivirals, and for treatment of cardiovascular, dermatological, respiratory, central nervous system, gastro-intestinal diseases, autoimmune, metabolic, endocrine, musculo-skeletal, genitourinary, tissue and organ, ocular, ophthalmological, immune system, pain, kidney, urological, and bone diseases and disorders and for the treatment of fibromyalgia, smoking cessation, narcolepsy, excessive daytime sleepiness, alzheimer's disease agitation, migraine, diabetes, hypertension, skin disorders, allergies, asthma, obesity, and hair loss] and 5 [All items in this class are claimed in the convention application.]
Type of Mark: Word
Date of Acceptance: March 30
Registration Advertised: June 25
For further details contact Griffith Hack.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2639772.
Disclaimer: Curated by HT Syndication.
